116
Views
0
CrossRef citations to date
0
Altmetric
Review

Molecular Antimicrobial Susceptibility Testing in Sepsis

ORCID Icon, , , , , , , & show all
Pages 61-72 | Received 30 May 2023, Accepted 01 Sep 2023, Published online: 05 Jan 2024

References

  • Nunnally ME , Ferrer R , Martin GS et al.> The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis. Intensive Care Med. Exp. 9(1), 34 (2021).
  • De Waele JJ , Girardis M , Martin-Loeches I . Source control in the management of sepsis and septic shock. Intensive Care Med. 48(12), 1799–1802 (2022).
  • Rhee C , Dantes R , Epstein L et al.> Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA 318(13), 1241–1249 (2017).
  • Rhee C , Jones TM , Hamad Y et al.> Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw. Open 2(2), e187571–e187571 (2019).
  • Fleischmann-Struzek C , Goldfarb DM , Schlattmann P , Schlapbach LJ , Reinhart K , Kissoon N . The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir. Med. 6(3), 223–230 (2018).
  • Kerrigan SW , Martin-Loeches I . Public awareness of sepsis is still poor: we need to do more. Intensive Care Med. 44(10), 1771–1773 (2018).
  • Rudd KE , Johnson SC , Agesa KM et al.> Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease study. Lancet 395(10219), 200–211 (2020).
  • Garduno A , Martinez GS , Ostadgavahi AT , Kelvin D , Cusack R , Martin-Loeches I . Parallel dysregulated immune response in severe forms of COVID-19 and bacterial sepsis via single-cell transcriptome sequencing. Biomedicines 11(3), 778 (2023).
  • Martin-Loeches I , Levy MM , Artigas A . Management of severe sepsis: advances, challenges, and current status. Drug Des. Devel. Ther. 9, 2079–2088 (2015).
  • Rubio I , Osuchowski MF , Shankar-Hari M et al.> Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect. Dis. 19(12), e422–e436 (2019).
  • Singer M , Deutschman CS , Seymour CW et al.> The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8), 801–810 (2016).
  • Vallés J , Palomar M , Alvárez-Lerma F et al.> Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia. Crit. Care Med. 41(1), 76–83 (2013).
  • Zilahi G , Artigas A , Martin-Loeches I . What’s new in multidrug-resistant pathogens in the ICU? Ann. Intensive Care 6(1), 96 (2016).
  • Perez KK , Olsen RJ , Musick WL et al.> Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch. Pathol. Lab. Med. 137(9), 1247–1254 (2013).
  • Martin-Loeches I , Timsit JF , Leone M et al.> Clinical controversies in abdominal sepsis. Insights for critical care settings. J. Crit. Care 53, 53–58 (2019).
  • Montravers P , Martin-Loeches I . Source control and intra-abdominal infections: still many questions and only limited answers. J. Crit. Care 52, 265–266 (2019).
  • Tjandra KC , Ram-Mohan N , Abe R et al.> Diagnosis of bloodstream infections: an evolution of technologies towards accurate and rapid identification and antibiotic susceptibility testing. Antibiotics (Basel) 11(4), 511 (2022).
  • Phua J , Ngerng WJ , See KC et al.> Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit. Care 17(5), R202 (2013).
  • Nannan Panday RS , Lammers EMJ , Alam N , Nanayakkara PWB . An overview of positive cultures and clinical outcomes in septic patients: a sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial. Crit. Care 23(1), 182 (2019).
  • El-Bouri K , Johnston S , Rees E et al.> Comparison of bacterial identification by MALDI-TOF mass spectrometry and conventional diagnostic microbiology methods: agreement, speed and cost implications. Br. J. Biomed. Sci. 69(2), 47–55 (2012).
  • Elbehiry A , Marzouk E , Abalkhail A et al.> The development of technology to prevent, diagnose, and manage antimicrobial resistance in healthcare-associated infections. Vaccines (Basel) 10(12), 2100 (2022).
  • Angeletti S . Matrix-assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology. J. Microbiol. Methods 138, 20–29 (2017).
  • Sinha M , Jupe J , Mack H , Coleman TP , Lawrence SM , Fraley SI . Emerging technologies for molecular diagnosis of sepsis. Clin. Microbiol. Rev. 31(2), e00089-17 (2018).
  • Weis C , Cuénod A , Rieck B et al.> Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning. Nat. Med. 28(1), 164–174 (2022).
  • Legba BB , Dougnon V , Koudokpon H et al.> Assessment of blood cultures and antibiotic susceptibility testing for bacterial sepsis diagnosis and utilization of results by clinicians in Benin: a qualitative study. Front. Public Health 10, 1088590 (2022).
  • Reuter CH , Palac HL , Kociolek LK et al.> Ideal and actual impact of rapid diagnostic testing and antibiotic stewardship on antibiotic prescribing and clinical outcomes in children with positive blood cultures. Pediatr. Infect. Dis. J. 38(2), 131–137 (2019).
  • Ohnuma T , Chihara S , Costin B et al.> Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US. JAMA Netw. Open 6(1), e2249353 (2023).
  • Usman OA , Usman AA , Ward MA . Comparison of SIRS, qSOFA, and NEWS for the early identification of sepsis in the emergency department. Am. J. Emerg. Med. 37(8), 1490–1497 (2019).
  • Mizrahi A , Jaureguy F , Petit H et al.> Early empirical antibiotic therapy modification in sepsis using beta-lacta test directly on blood cultures. Int. J. Transl. Med. 2(3), 448–455 (2022).
  • Klein Klouwenberg PMC , Cremer OL , van Vught LA et al.> Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit. Care 19(1), 319 (2015).
  • Arulkumaran N , Routledge M , Schlebusch S , Lipman J , Conway Morris A . Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med. 46(2), 225–235 (2020).
  • Evans L , Rhodes A , Alhazzani W et al.> Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47(11), 1181–1247 (2021).
  • Cassini A , Hogberg LD , Plachouras D et al.> Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect. Dis. 19(1), 56–66 (2019).
  • Rhee C , Yu T , Wang R et al.> Association between implementation of the severe sepsis and septic shock early management bundle performance measure and outcomes in patients with suspected sepsis in US hospitals. JAMA Netw. Open 4(12), e2138596–e2138596 (2021).
  • Liang SY , Kumar A . Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance. Curr. Infect. Dis. Rep. 17(7), 493 (2015).
  • Zaragoza R , Vidal-Cortés P , Aguilar G et al.> Update of the treatment of nosocomial pneumonia in the ICU. Crit. Care 24(1), 383 (2020).
  • Briggs N , Campbell S , Gupta S . Advances in rapid diagnostics for bloodstream infections. Diagn. Microbiol. Infect. Dis. 99(1), 115219 (2021).
  • Castro Méndez C , Carmen Serrano M , Valverde A , Pemán J , Almeida C , Martín-Mazuelos E . Comparison of E-Test®, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes. Med. Mycol. 46(2), 119–123 (2008).
  • Smith KP , Kirby JE . Rapid susceptibility testing methods. Clin. Lab. Med. 39(3), 333–344 (2019).
  • Katsanis SH , Katsanis N . Molecular genetic testing and the future of clinical genomics. Nat. Rev. Genet. 14(6), 415–426 (2013).
  • Vasala A , Hytönen VP , Laitinen OH . Modern tools for rapid diagnostics of antimicrobial resistance. Front. Cell. Infect. Microbiol. https://doi.org/10.3389/fcimb.2020.00308 (2020).
  • Banerjee R , Humphries R . Rapid antimicrobial susceptibility testing methods for blood cultures and their clinical impact. Front. Med. (Lausanne) 8, 635831 (2021).
  • Khan ZA , Siddiqui MF , Park S . Current and emerging methods of antibiotic susceptibility testing. Diagnostics (Basel) 9(2), 49 (2019).
  • Dadgostar P . Antimicrobial resistance: implications and costs. Infect. Drug Resist. 12, 3903–3910 (2019).
  • Rayman G , Akpan A , Cowie M et al.> Managing patients with comorbidities: future models of care. Future Healthc. J. 9(2), 101–105 (2022).
  • Sakagianni A , Koufopoulou C , Feretzakis G et al.> Using machine learning to predict antimicrobial resistance–a literature review. Antibiotics 12(3), 452 (2023).
  • Avershina E , Khezri A , Ahmad R . Clinical diagnostics of bacterial infections and their resistance to antibiotics–current state and whole genome sequencing implementation perspectives. Antibiotics 12(4), 781 (2023).
  • Seymour CW , Kahn JM , Martin-Gill C et al.> Delays from first medical contact to antibiotic administration for sepsis. Crit. Care Med. 45(5), 759–765 (2017).
  • Martin-Loeches I , Garduno A , Povoa P , Nseir S . Choosing antibiotic therapy for severe community-acquired pneumonia. Curr. Opin. Infect. Dis 35(2), 133–139 (2022).
  • Gutiérrez-Pizarraya A , Leone M , Garnacho-Montero J , Martin C , Martin-Loeches I . Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis. Expert Rev. Clin. Pharmacol. 10(4), 457–465 (2017).
  • Rhee C , Kadri SS , Dekker JP et al.> Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw. Open 3(4), e202899–e202899 (2020).
  • Bouza E , Sousa D , Muñoz P , Rodríguez-Créixems M , Fron C , Lechuz JG . Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin. Infect. Dis. 39(8), 1161–1169 (2004).
  • Magiorakos AP , Srinivasan A , Carey RB et al.> Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18(3), 268–281 (2012).
  • Martin-Loeches I , Torres A , Rinaudo M et al.> Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J. Infect. 70(3), 213–222 (2015).
  • Majumder MAA , Rahman S , Cohall D et al.> Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect. Drug Resist. 13, 4713–4738 (2020).
  • Russell L , Pène F , Martin-Loeches I . Multidrug-resistant bacteria in the grey shades of immunosuppression. Intensive Care Med. 49(2), 216–218 (2023).
  • Nassar H , Abu-Farha R , Barakat M , Alefishat E . Antimicrobial stewardship from health professionals’ perspective: awareness, barriers, and level of implementation of the program. Antibiotics 11(1), 99 (2022).
  • Llor C , Bjerrum L . Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther. Adv. Drug Saf. 5(6), 229–241 (2014).
  • Chung GW , Wu JE , Yeo CL , Chan D , Hsu LY . Antimicrobial stewardship: a review of prospective audit and feedback systems and an objective evaluation of outcomes. Virulence 4(2), 151–157 (2013).
  • Timbrook TT , Morton JB , McConeghy KW , Caffrey AR , Mylonakis E , LaPlante KL . The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin. Infect. Dis. 64(1), 15–23 (2017).
  • Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect. Dis. 17(11), 1133–1161 (2017).
  • Abdul-Aziz MH , Alffenaar JC , Bassetti M et al.> Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper. Intensive Care Med. 46(6), 1127–1153 (2020).
  • Ulldemolins M , Vaquer S , Llauradó-Serra M et al.> Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. Crit. Care 18(3), 227 (2014).
  • Pandolfi F , Brun-Buisson C , Guillemot D , Watier L . One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality–a French nationwide study. Crit. Care 26(1), 371 (2022).
  • Peri AM , Bauer MJ , Bergh H , Butkiewicz D , Paterson DL , Harris PNA . Performance of the BioFire Blood Culture Identification 2 panel for the diagnosis of bloodstream infections. Heliyon 8(7), e09983 (2022).
  • Martin-Loeches I . Therapeutic drug monitoring (TDM) in real-time: a need for the present future. Expert Rev. Anti Infect. Ther. 20(10), 1245–1247 (2022).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.